Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
MAXIPHARMA A/S
A/S
Active
Reklamebeskyttelse
CVR 87375617
Søren Nymarks Vej 25, 8270
Højbjerg
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 1979 · 47 years old
3 employees
Overvåg
Share
Denmark
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
MAXIPHARMA A/S
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
1M
1M
2M
2M
2M
2020
2M
2021
2M
2022
2M
2023
2M
2024
EBITDA
DKK millions
1M
1M
1M
0M
0M
1M
2020
1M
0%
2021
1M
0%
2022
1M
0%
2023
1M
0%
2024
Income statement
DKK thousands
Item
2020
2021
2022
2023
2024
Gross profit
1.534
1.683
2.022
1.825
2.145
Staff expenses
-889
-971
-1.045
-1.287
-1.631
EBITDA
645
711
978
538
514
Depreciation & amort.
-65
-57
-8
-0
-0
EBIT
580
654
970
538
514
Net financials
377
613
-630
-248
14
Profit before tax
957
1.267
340
290
528
Tax
211
279
75
64
116
Net profit
746
988
265
226
411
Balance sheet
DKK thousands
Item
2020
2021
2022
2023
2024
Total assets
4.873
5.069
5.097
5.206
4.881
Equity
3.395
3.683
3.744
3.766
3.974
Long-term debt
36
0
0
0
0
Short-term debt
1.442
1.386
1.353
1.440
896
Total debt
1.479
1.386
1.353
1.440
896
Financial ratios
5-year trend
EBITDA-margin (af bruttofortjeneste)
23.9%
This company
2020
2024
Soliditetsgrad
81.4%
This company
38.2%
Market median
+113% vs market
2020
2024
Egenkapitalforrentning
10.4%
This company
18.4%
Market median
+43% vs market
2020
2024
Nettoresultatgrad (af bruttofortjeneste)
19.2%
This company
2020
2024
Aktivomsætning (af bruttofortjeneste)
0.44×
This company
2020
2024
Gæld/egenkapital
0.23×
This company
0.62×
Market median
+63% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
View
PDF
More on MAXIPHARMA A/S
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
